This inventor holds 2 USPTO granted patents. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1993-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-2009
Title: Makoto Murata: Innovator in Pharmaceutical Chemistry
Introduction
Makoto Murata is a distinguished inventor based in Hirakata, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Murata's work focuses on compounds that have potential therapeutic applications.
Latest Patents
Murata's latest patents include the development of 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same. This invention provides 2-furancarboxylic acid hydrazide compounds represented by a specific general formula. These compounds are designed to exhibit various physiological properties, making them valuable in medical applications. Additionally, he has worked on Tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine derivatives, which show excellent aldose reductase inhibitory activity. These derivatives are useful for the prevention and treatment of diabetic complications.
Career Highlights
Makoto Murata is currently associated with Dainippon Pharmaceutical Company, Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions in the pharmaceutical industry.
Collaborations
Murata has collaborated with notable colleagues, including Toshiyuki Negoro and Buichi Fujitani. These partnerships have contributed to the success of his research and the development of his patented inventions.
Conclusion
In summary, Makoto Murata is a prominent inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. His innovative patents reflect his commitment to improving healthcare through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
